We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Hipgnosis Songs Fund shares up after confirmation of portfolio value

Thu, 28th Mar 2024 11:26

(Alliance News) - Hipgnosis Songs Fund Ltd on Thursday confirmed the valuation of its portfolio was in line with an earlier estimate, giving its shares a boost.

The music investment and song management company turned to independent advisor Shot Tower Capital LLC to determine the fair market value of the company's portfolio. Shot Tower gave a preliminary value between USD1.80 billion and USD2.06 billion.

A final valuation, announced Thursday, of USD1.95 billion was given, so in line with the previous findings.

Looking ahead, the board plans to announce the conclusion of the strategic review by April 26, along with proposals for the future of the company.

Hipgnosis shares were up 8.0% to 68.82 pence each in London, as Thursday's announcement offered it some share price relief after a difficult past few months. Shares are down 15% over the past 12 months.

Last year, the embattled investor in music rights said an independent valuer, Citrin Cooperman, found its assets had a value "materially higher than the valuation implied by proposed and recent transactions in the sector".

Last week Monday, the company reported an "identification of an error" of its net asset value calculation, meanwhile, caused by "double counting" of accrued revenue. This caused the pro-forma operative NAV to be reduced to 107.65 cents or 85.03p per share. Earlier in March, it said its operative NAV at September 30 was 173.92 US cents, or 142.49 pence.

Also earlier this month, it said it will divert its free cashflow toward paying down debt and won't resume paying dividends "for the foreseeable future".

Hipgnosis Songs is also locked in a dispute with founder Merck Mercuriadis.

The dispute was sparked by an arrangement, later rejected by Hipgnosis Songs Fund shareholders, to sell part of the fund's portfolio to a joint-venture between Hipgnosis Songs Management and private equity firm Blackstone Inc. Mercuriadis last month stepped down as chief executive of Hipgnosis Songs Management, and the board of Hipgnosis Songs Fund also changed. The two sides currently are squaring off in UK High Court.

By Elijah Dale, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
28 Apr 2024 15:47

Blackstone to make improved bid for Hipgnosis, Sky News reports

April 28 (Reuters) - Private equity giant Blackstone is preparing to lodge an improved bid for Hipgnosis Songs Fund which owns the music rights of a...

28 Apr 2024 15:06

Blackstone to make improved bid for Hipgnosis, Sky News reports

April 28 (Reuters) - Private equity giant Blackstone is preparing to lodge an improved bid for Hipgnosis Songs Fund which owns the music rights of art...

24 Apr 2024 19:33

TOP NEWS: Concord looks to thwart Blackstone with raised Hipgnosis bid

(Alliance News) - Hipgnosis Songs Fund Ltd on Wednesday said it had reached an agreement on the terms of an increased takeover offer from music rights...

24 Apr 2024 09:02

LONDON BROKER RATINGS: Investec cuts Hipgnosis Songs Fund to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

22 Apr 2024 17:21

London shares climb over 1%, M&A action lifts midcap stocks

FTSE 100 up 1.6%, FTSE 250 adds 1.1% *

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.